NovoBiome
PrivateLast Round
Accelerator
Jan 14, 2026
Total Funding Raised
$2.17M
Company Overview
NovoBiome operates in Healthcare & Life Sciences and is based in Latresne. Its latest recorded funding round was an Accelerator round in January 2026.
NovoBiome is a biotechnology company that develops Live Biotherapeutics Products (LBPs) and a proprietary ex-vivo research platform, NovoSift®, to target the microbiome-gut-liver axis for the treatment of liver diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NovoBiome Comparables
Compare NovoBiome with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| YSOPIA Bioscience | 84% | |
| Caelus Health | 80% | |
| Enterome | 78% |
For institutional investors. Book with your work email.
NovoBiome Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Jan 14, 2026 | ||||
| Grant | Feb 17, 2025 | ||||
| Seed | May 29, 2024 | ||||
| Grant | Jun 7, 2021 |
For institutional investors. Book with your work email.
NovoBiome Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| Noshaq | Seed |
| CiRi Ventures | Seed |
| Climate Insiders | Seed |
| Cycle Momentum | Accelerator |
| Planetary Impact Ventures | Seed |
| The Biomimicry Institute | Grant |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 17, 2025
Received funding from the European Innovation Council Fund.
For institutional investors. Book with your work email.
NovoBiome Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about NovoBiome's valuation, stock price, and market status.
Is NovoBiome a public or private company?
NovoBiome is a private company.
What is the current stock price of NovoBiome?
NovoBiome is a private company, so its shares have no public market price. Caplight tracks NovoBiome's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NovoBiome worth (valuation)?
Valuation information for NovoBiome is not publicly available.
Can I buy NovoBiome stock?
NovoBiome shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NovoBiome's last funding round?
NovoBiome's most recent funding round was Accelerator on January 14, 2026.
Who are the main investors in NovoBiome?
Key investors in NovoBiome include European Innovation Council Fund, Noshaq, The Biomimicry Institute.
Will NovoBiome IPO soon?
No public IPO plans have been announced for NovoBiome.
How can I track NovoBiome secondary market activity?
Caplight tracks bids, offers, and trades in NovoBiome's shares on secondary markets.